Warren Buffett Bristol Myers Squibb CO Transaction History

Berkshire Hathaway Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $320 Million - $384 Million	-5,202,674 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $903 Million - $1.05 Billion	-16,844,262 Reduced 76.4%	5,202,674 $324 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $251 Million - $294 Million	-4,247,330 Reduced 16.15%	22,046,936 $1.3 Billion
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $293 Million - $319 Million	-4,737,961 Reduced 15.27%	26,294,266 $1.76 Billion
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $137 Million - $154 Million	-2,303,789 Reduced 6.91%	31,032,227 $1.96 Billion
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $194 Million - $220 Million	3,364,822 Added 11.23%	33,336,016 $2.07 Billion
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $1.72 Billion - $1.91 Billion	29,971,194 New	29,971,194 $1.81 Billion

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Berkshire Hathaway Inc, based on Form 13F filings with the SEC.

Stay updated on Berkshire Hathaway Inc and Warren Buffett with notifications on news.